首页|小青龙汤合三子养亲汤治疗小儿咳嗽变异性哮喘风寒袭肺证临床观察

小青龙汤合三子养亲汤治疗小儿咳嗽变异性哮喘风寒袭肺证临床观察

扫码查看
目的 观察小青龙汤合三子养亲汤治疗小儿咳嗽变异性哮喘(CVA)风寒袭肺证的临床疗效.方法 将92 例CVA风寒袭肺证患儿按照随机数字表法分为2 组,对照组46 例予西医常规治疗,治疗组46 例在对照组治疗基础上应用小青龙汤合三子养亲汤.2 组均治疗4 周.比较2 组疗效;比较 2 组治疗前后肺功能指标用力肺活量(FVC)、第1s用力呼气容积(FEV1)、最大呼气峰流速(PEF)变化;比较2 组治疗前后气道高反应性;比较2 组治疗前后血清白细胞介素4(IL-4)、IL-5 及外周血嗜酸性粒细胞(EOS)水平变化;观察 2 组痊愈患儿复发情况;进行安全性评估.结果 治疗组总有效率91.30%(42/46),对照组总有效率 76.09%(35/46),治疗组疗效优于对照组(P<0.05).2 组治疗后FVC、FEV1、PEF均较本组治疗前升高(P<0.05),治疗后治疗组FVC、FEV1、PEF均高于对照组(P<0.05).2 组治疗后最小诱发累积剂量、促使呼吸阻力增加至基础值135%所消耗组胺累积量(PD35)均较本组治疗前增加(P<0.05),治疗后治疗组最小诱发累积剂量、PD35 均大于对照组(P<0.05).2 组治疗后血清IL-4、IL-5 及外周血EOS水平均较本组治疗前降低(P<0.05),治疗后治疗组血清IL-4、IL-5 及外周血EOS水平均低于对照组(P<0.05).治疗组复发率33.33%(8/24),对照组复发率88.24%(15/17),治疗组复发率低于对照组(P<0.05).结论 小青龙汤合三子养亲汤治疗小儿CVA风寒袭肺证,能改善患儿肺功能,降低气道高反应性,调节血清IL-4、IL-5 及外周血EOS水平,且能降低复发率,疗效显著.
Clinical observation of Xiaoqinglong Decoction and Sanzi Yangqin Decoction on pediatric cough variant asthma with wind-cold attacking lung syndrome
Objective To observe the effects of Xiaoqinglong Decoction combined with Sanzi Yangqin Decoction on ped-iatric cough variant asthma(CVA)with wind-cold attacking lung syndrome.Methods A total of 92 pediatric CVA with wind-cold attacking lung syndromewere randomly assigned into the control group(n =46)and the treatment group(n =46).The pa-tients in the treatment groupwere additionally given Xiaoqinglong Decoction combined with Sanzi Yangqin Decoction on the basis of conventional treatment.A 4-week treatment was performed in the both groups,aiming to compare the curative effect,the lev-els of forced vital capacity(FVC),forced expiratory volume in one second(FEV1)and peak expiratory flow(PEF),and airway hyperresponsiveness(AHR),as well as the levels of serum interleukin-4(IL-4),IL-5 and peripheral blood eosinophil(EOS)before and after treatment between groups.The recurrence and conduct safety assessments in the two groups were ob-served.Results The total effective rate in the treatment group wasbetter than that in the control group(91.30%[42/46]vs 76.09%[35/46],P<0.05).After treatment,FVC,FEV1 and PEF in the two groups were significantly increased(P<0.05),and the increase was more prevalent in the treatment group(P<0.05).The log minimum dose(Dmin)and provoking dose(PD35)in the two groups were significantly increased(P<0.05),and the increase was more pronounced in the treatment group(P<0.05).The levels of serum IL-4,IL-5 and peripheral blood EOS in the two groups were significantly lower(P<0.05),which were significantly lower in the treatment group than the control group(P<0.05).The recurrence rate of the treat-ment group was significantly lower than the control group(33.33%[8/24]vs 88.24%[15/17],P<0.05).Conclusion For children with CVA with wind-cold attacking lung syndrome,Xiaoqinglong Decoction combined with Sanzi Yangqin Decoction can improve their lung function,reduce AHR,regulate the levels of serum IL-4,IL-5 and peripheral blood EOS,and reduce the recurrence rate,with significant curative effect.

CoughTraditional Chinese medicine therapyDecoctionAsthmaXiaoqinglong DecoctionSanzi Yangqin Decoction

凌钦亮、吴杰妍、李云海

展开 >

广州中医药大学第三附属医院儿科,广东 广州 510000

咳嗽 中药疗法 汤剂 哮喘 小青龙汤 三子养亲汤

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(3)
  • 22